Pacific Edge Limited
Pacific Edge Limited, a cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients. It operates through two segments, Commercial and Research. The company offers Cxbladder, a genomic urine biomarker test for the detection and surveillance of bladder cancer. It also develops Cxbladder Triage, a frontline diagnostic produc… Read more
Pacific Edge Limited (PFGTF) - Total Liabilities
Latest total liabilities as of September 2025: $7.71 Million USD
Based on the latest financial reports, Pacific Edge Limited (PFGTF) has total liabilities worth $7.71 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Pacific Edge Limited - Total Liabilities Trend (2005–2025)
This chart illustrates how Pacific Edge Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Pacific Edge Limited Competitors by Total Liabilities
The table below lists competitors of Pacific Edge Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SEPC Limited
NSE:SEPC
|
India | ₹10.52 Billion |
|
P/F BankNordik
CO:BNORDIK-CSE
|
Denmark | Dkr11.58 Billion |
|
SA Catana Group
PA:CATG
|
France | €126.23 Million |
|
Action Electronics Co Ltd
TW:3024
|
Taiwan | NT$1.50 Billion |
|
BusinessOn Communication Co. Ltd
KQ:138580
|
Korea | ₩26.05 Billion |
|
East Tender Opto
TWO:6588
|
Taiwan | NT$236.33 Million |
|
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS
IS:GENIL
|
Turkey | TL7.52 Billion |
|
Socovesa
SN:SOCOVESA
|
Chile | CL$692.04 Billion |
Liability Composition Analysis (2005–2025)
This chart breaks down Pacific Edge Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.10 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Pacific Edge Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Pacific Edge Limited (2005–2025)
The table below shows the annual total liabilities of Pacific Edge Limited from 2005 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | $10.95 Million | +1.10% |
| 2024-03-31 | $10.83 Million | +24.35% |
| 2023-03-31 | $8.71 Million | +17.18% |
| 2022-03-31 | $7.43 Million | +22.30% |
| 2021-03-31 | $6.08 Million | +25.93% |
| 2020-03-31 | $4.82 Million | +81.63% |
| 2019-03-31 | $2.66 Million | -12.20% |
| 2018-03-31 | $3.02 Million | +10.63% |
| 2017-03-31 | $2.73 Million | +8.36% |
| 2016-03-31 | $2.52 Million | +30.69% |
| 2015-03-31 | $1.93 Million | +102.56% |
| 2014-03-31 | $953.17K | -11.55% |
| 2013-03-31 | $1.08 Million | +11.22% |
| 2012-03-31 | $968.83K | +60.31% |
| 2011-03-31 | $604.35K | -10.08% |
| 2010-03-31 | $672.12K | +5.11% |
| 2009-03-31 | $639.44K | -15.03% |
| 2008-03-31 | $752.52K | +232.75% |
| 2007-03-31 | $226.16K | -29.48% |
| 2006-03-31 | $320.70K | +20.70% |
| 2005-03-31 | $265.71K | -- |